Xenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.81), $0.01 better than the analyst estimate of ($0.82). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.